Short Interest in MariMed Inc. (OTCMKTS:MRMD) Declines By 63.1%

MariMed Inc. (OTCMKTS:MRMDGet Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 57,300 shares, a decrease of 63.1% from the February 28th total of 155,100 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average trading volume of 723,400 shares, the days-to-cover ratio is presently 0.1 days.

MariMed Trading Down 2.1 %

Shares of MRMD traded down $0.00 during midday trading on Friday, hitting $0.10. 184,179 shares of the stock were exchanged, compared to its average volume of 376,969. The firm has a market cap of $36.93 million, a P/E ratio of -2.42 and a beta of 2.70. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.73 and a current ratio of 1.55. The stock has a fifty day simple moving average of $0.12 and a 200 day simple moving average of $0.14. MariMed has a 52-week low of $0.09 and a 52-week high of $0.34.

MariMed (OTCMKTS:MRMDGet Free Report) last posted its quarterly earnings results on Wednesday, March 5th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). MariMed had a negative net margin of 10.97% and a negative return on equity of 2.75%. The business had revenue of $39.00 million during the quarter, compared to the consensus estimate of $42.00 million.

MariMed Company Profile

(Get Free Report)

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.

Recommended Stories

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.